Access to Medicines by Seguro Popular Beneficiaries: Pending Tasks towards Universal Health Coverage

نویسندگان

  • Edson Servan-Mori
  • Ileana Heredia-Pi
  • Julio Montañez-Hernandez
  • Leticia Avila-Burgos
  • Veronika J. Wirtz
  • Abdisalan Mohamed Noor
چکیده

OBJECTIVE In the context of aiming to achieve universal health coverage in Mexico, this study compares access to prescribed medicines (ATPM) between Seguro Popular (SP) and non-SP affiliated outpatient health service users. MATERIALS AND METHODS ATPM by 6,123 users of outpatient services was analyzed using the National Health and Nutrition Survey 2012. Adjusted bi-probit models were performed incorporating instrumental variables. RESULTS 17.3% of SP and 10.1% of the non-SP population lacked ATPM. Two-thirds of all outpatient SP and 18.5% of all outpatient non-SP received health services at Ministry of Health facilities, among whom, 64.6 and 53.6% of the SP and non-SP population respectively reported ATPM at these facilities. Lack of medicines in health units, chronic health problems (compared to acute conditions) and prescription ≥3 medicines were risk factors for non-ATPM. Adjusted models suggest that when using Ministry of Health services, the SP population has a higher probability of ATMP compared to the non-SP population. CONCLUSION Given the aspirations of achieving universal health coverage in Mexico, it is important to increase ATPM in Ministry of Health facilities thereby ensuring basic rights to health care are met.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Design and base-line evaluation of financial incentives to increase effective coverage of priority health interventions funded by Seguro Popular, Mexico

Content Mexico’s Seguro Popular has contributed towards universal financial risk protection. However, coverage is low for chronic diseases, with only 26% and 30% of affiliate adult men and women, respectively, having access to preventive care. The state of Hidalgo’s Seguro Popular affiliating 3.4 million people introduced a results-based financial incentive scheme to improve performance of key ...

متن کامل

A new entity for the negotiation of public procurement prices for patented medicines in Mexico.

PROBLEM As countries expand health insurance coverage, their expenditures on medicines increase. To address this problem, WHO has recommended that every country draw up a list of essential medicines. Although most medicines on the list are generics, in many countries patented medicines represent a substantial portion of pharmaceutical expenditure. APPROACH To help control expenditure on paten...

متن کامل

Informality and the expansion of social protection programs: evidence from Mexico.

Many countries are moving from employer-based to universal health coverage, which can generate crowd out. In Mexico, Seguro Popular provides public health coverage to the uninsured. Using the gradual roll-out of the system at the municipality level, we estimate that Seguro Popular had no effect on informality in the overall population. Informality did increase by 1.7% for less educated workers,...

متن کامل

Gaps in universal health coverage in Malawi: A qualitative study in rural communities

BACKGROUND In sub-Saharan Africa, universal health coverage (UHC) reforms have often adopted a technocratic top-down approach, with little attention being paid to the rural communities' perspective in identifying context specific gaps to inform the design of such reforms. This approach might shape reforms that are not sufficiently responsive to local needs. Our study explored how rural communit...

متن کامل

Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies

BACKGROUND Many middle-income countries are scaling up health insurance schemes to provide financial protection and access to affordable medicines to poor and uninsured populations. Although there is a wealth of evidence on how high income countries with mature insurance schemes manage cost-effective use of medicines, there is limited evidence on the strategies used in middle-income countries. ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 10  شماره 

صفحات  -

تاریخ انتشار 2015